semaglutide alcohol use disorder Wegovy and Ozempic (semaglutide) are associated with a 50-56% reduction in addiction RCT: Semaglutide reduces alcohol craving

Key Takeaways for Patients Considering GLP-1 at Home I recommend understanding that BMI is a guideline, but your overall health determines eligibility

Scapin G

These lawsuits emphasize the need for comprehensive information about the risks associated with medications like Ozempic and Wegovy, and the accountability of pharmaceutical companies in ensuring the safety of their products

By type of agonist the market is single-agonist, dual-agonist and tri-agonist, by route of administration market is categorized into oral and parenteral, by target indication market is categorized into Alzheimers disease, non-alcoholic steatohepatitis, obesity, sleep apnea, type 2 diabetes

For a comprehensive list of potential side effects, drug interactions, and precautions, please refer to the official pharmaceutical documentation

Table 1 Signal detection for adverse events (AEs) of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with psychiatric AEs (pAEs) in the FDA Adverse Event Reporting System (FAERS) database from 2004 to 2023